Advanced search
Publication Cover
Cytokines, Cellular & Molecular Therapy Volume 6, 2000 - Issue 2
Journal homepage
3
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Effect of interferon-α on CD20 antigen expression of B–cell chronic lymphocytic leukemia

S Sivaraman Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
P Venugopal Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
R Ranganathan Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
CG Deshpande Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
X Huang Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
A Jajeh Cook County Hospital, Chicago, IL, USA
,
SA Gregory Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
,
T O’Brien Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
&
HD Preisler Rush Cancer Institute, Rush Presbyterian–St Luke’s Medical Center, Chicago, IL, USA
 show all
Pages 81-87 | Published online: 26 Sep 2009

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sigbjørn Berentsen, Klaus Beiske & Geir E. Tjønnfjord. (2007) Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy. Hematology 12:5, pages 361-370.
Read now
Carol S. Portlock, Owen A. O'Connor, David J. Straus, Lisa Rosenzweig, Otilia Dumitrescu, Oscar Lin & Peter Maslak. (2006) Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?. Leukemia & Lymphoma 47:7, pages 1260-1264.
Read now

Articles from other publishers (28)

Qiong Li, Naya Ma, Xinlei Li, Chao Yang, Wei Zhang, Jingkang Xiong, Lidan Zhu, Jiali Li, Qin Wen, Lei Gao, Cheng Yang, Lingyi Rao, Li Gao, Xi Zhang & Jun Rao. (2023) Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. Chinese Medical Journal 136:12, pages 1448-1458.
Crossref
Anna Furlan, Maria Cristina Rossi, Filippo Gherlinzoni & Piergiorgio Scotton. (2022) Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution. Hematology Reports 14:2, pages 135-142.
Crossref
Amber Blaauboer, Kostandinos Sideras, Casper H.J. van Eijck & Leo J. Hofland. (2021) Type I interferons in pancreatic cancer and development of new therapeutic approaches. Critical Reviews in Oncology/Hematology 159, pages 103204.
Crossref
Chan Gyu Lee, TaeEun Kim, Sungyoul Hong, Jongwan Chu, Ju Eun Kang, Hee Geon Park, Jun Young Choi, Kyoung Song, Sun Young Rha, Soohyeon Lee, Joon-Seok Choi, Sun Min Kim, Hae Min Jeong & Young Kee Shin. (2021) Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing. Frontiers in Pharmacology 11.
Crossref
Ernest C. Borden. (2019) Interferons α and β in cancer: therapeutic opportunities from new insights. Nature Reviews Drug Discovery 18:3, pages 219-234.
Crossref
Li Zhang, Yu-Tzu Tai, Matthew Zhi Guang Ho, Lugui Qiu & Kenneth C. Anderson. (2017) Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era. Experimental Hematology & Oncology 6:1.
Crossref
Kazumi Hayashi, Eijiro Nagasaki, Shin Kan, Masaki Ito, Yuko Kamata, Sadamu Homma & Keisuke Aiba. (2016) Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation. Cancer Science 107:5, pages 682-689.
Crossref
Indira Benakanakere, Tyler Johnson, Richard Sleightholm, Virgilio Villeda, Monika Arya, Ravi Bobba, Carl Freter & Chunfa Huang. (2014) Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells. Experimental Hematology & Oncology 3:1.
Crossref
Magdalena Winiarska, Dominika Nowis, Jacek Bil, Eliza Glodkowska-Mrowka, Angelika Muchowicz, Malgorzata Wanczyk, Kamil Bojarczuk, Michal Dwojak, Malgorzata Firczuk, Ewa Wilczek, Malgorzata Wachowska, Katarzyna Roszczenko, Marta Miaczynska, Justyna Chlebowska, Grzegorz Wladyslaw Basak & Jakub Golab. (2012) Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity. Journal of Biological Chemistry 287:38, pages 31983-31993.
Crossref
Holbrook E Kohrt, Roch Houot, Aurélien Marabelle, Hearn Jay Cho, Keren Osman, Matthew Goldstein, Ronald Levy & Joshua Brody. (2012) Combination strategies to enhance antitumor ADCC. Immunotherapy 4:5, pages 511-527.
Crossref
Guillaume Cartron, Ralf Ulrich Trappe, Philippe Solal-Céligny & Michael Hallek. (2011) Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies. Clinical Cancer Research 17:1, pages 19-30.
Crossref
Caiyun XuanKristopher K. Steward, John M. Timmerman & Sherie L. Morrison. (2010) Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma. Blood 115:14, pages 2864-2871.
Crossref
Shu-qing Lü, Jian-min Yang, Xian-min Song, Li Chen, Wei-ping Zhang, Xiao-qian Xu, Xiong Ni, Chong-mei Huang, Yi He & Jian-min Wang. (2010) CHOP-like regimen in combination with rituximab and peginterferon alpha-2b in newly-diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma: Experience in a Chinese center. Clinical Oncology and Cancer Research 7:2, pages 103-109.
Crossref
Amani Mankaï, Virginie Buhé, Mariam Hammadi, Pierre Youinou, Ibtissem Ghedira, Christian Berthou & Anne Bordron. (2009) Improvement of Rituximab Efficiency in Chronic Lymphocytic Leukemia by CpG-Mediated Upregulation of CD20 Expression Independently of PU.1. Annals of the New York Academy of Sciences 1173:1, pages 721-728.
Crossref
C Hu, F S Wong & L Wen. (2009) Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases. Clinical and Experimental Immunology 157:2, pages 181-190.
Crossref
Prashant Kapoor, Patricia T. Greipp, William G. Morice, S. Vincent Rajkumar, Thomas E. Witzig & Philip R. Greipp. (2008) Anti-CD20 monoclonal antibody therapy in multiple myeloma. British Journal of Haematology 141:2, pages 135-148.
Crossref
Damodar Gupta, Meredith E. Crosby, Alexandru Almasan & Roger M. Macklis. (2008) Regulation of CD20 expression by radiation-induced changes in intracellular redox status. Free Radical Biology and Medicine 44:4, pages 614-623.
Crossref
Hossein Borghaei, Liat Binyamin, Igor Astsaturov & Louis M. Weiner. 2008. Molecular Targeting in Oncology. Molecular Targeting in Oncology 371 412 .
Tzu-Hsuan Huang, Koteswara R. Chintalacharuvu & Sherie L. Morrison. (2007) Targeting IFN-α to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities. The Journal of Immunology 179:10, pages 6881-6888.
Crossref
Nishitha Reddy, Francisco J. Hernandez-Ilizaliturri, George Deeb, Mark Roth, Mary Vaughn, Joy Knight, Paul Wallace & Myron S. Czuczman. (2007) Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo. British Journal of Haematology 0:0, pages 071113214049001-???.
Crossref
Andrew Zelenetz. 2006. The Lymphomas. The Lymphomas 249 277 .
Wojciech Wojciechowski, Huifen Li, Shannon Marshall, Chiara Dell’Agnola & Igor Espinoza-Delgado. (2005) Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms. The Journal of Immunology 174:12, pages 7859-7868.
Crossref
Ali R Jazirehi & Benjamin Bonavida. (2005) Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene 24:13, pages 2121-2143.
Crossref
Januario E. Castro & Thomas J. Kipps. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 329 340 .
Eva Kimby. (2002) Beyond immunochemotherapy: Combinations of rituximab with cytokines interferon-α2a and granulocyte-macrophage colony stimulating factor. Seminars in Oncology 29:2, pages 7-10.
Crossref
Philippe Solal-Céligny. (2002) Increasing treatment options in indolent non-Hodgkin's lymphoma. Seminars in Oncology 29:2, pages 2-6.
Crossref
Beatriz BellosilloNeus VillamorArmando López-GuillermoSilvia MarcéJordi EsteveElias CampoDolors ColomerEmili Montserrat. (2001) Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 98:9, pages 2771-2777.
Crossref
Kavita Maung, Amy I. D'Orazio, Bruce D. Cheson & Vinay K. Jain. (2001) Highlights From: 6th European Hematology Association Meeting, Frankfurt, Germany June 21–24, 2001. Clinical Lymphoma 2:2, pages 74-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.